Artur Isaev

Biography

 Artur Isaev holds MD from Rostov State Medical University (1994) and MBA from Moscow International Business School MIRBIS (1998). From 1994 to 1999 Artur Isaev headed an investment-brokerage company, from 1999 to 2003 he was a CEO of Mauer-Audit & Partners auditing and consulting group. Among other things, he was a co-investor in SMI-link project on the base of which Yandex. Traffic Jams internet service was created in Russia. In 2003 Artur Isaev founded Human Stem Cells Institute – a Russian biotech company, and in 2004 HSCI opened Gemabank® – one of Russia’s first cord blood banks, nowadays the largest family cord blood stem cell bank in Russia and CIS. In 2011 HSCI initiated and became a co-investor in SynBio – a long-term multilateral project to create new unique medicines (first-in-class and BioBetters). The SynBio project unites Russian and international biopharm companies, including Pharmsynthez and Xenetic Biosciences, and is supported by an investment from RUSNANO (a Russian state-owned fund for supporting nanotechnologies). Artur Isaev is a co-founder of IPOboard. He is the Winner of the Entrepreneur of the Year 2012 Award in hi-tech in Russia conducted by Ernst & Young.

Research Interest

His research interests include Tissue engineering, Gene therapy and DNA repair,Development of Diagnostic PCR panels, Therapeutic Angiogenesis